Researchers identify potent antibody cocktail to treat COVID-19

Researchers at the University of Maryland School of Medicine (UMSOM) said they identified a promising anti-viral cocktail therapy against COVID-19.

According to a news release, the researchers evaluated several human antibodies to determine the most potent combination to be mixed and used against SARS-CoV-2, the virus causing COVID-19. In collaboration with Regeneron Pharmaceuticals (NSDQ:REGN), UMSOM published results of a study in Science.

Just last week, Regeneron announced that it had initiated the first clinical trial of its dual antibody cocktail for preventing COVID-19, having already used the same “rapid response” approach to develop its REGN-EB3 antibody treatment for Ebola that is under review by the FDA.

The research was conducted using Regeneron’s proprietary genetically modified VelocImmune mice, which have a human immune system and antibodies isolated from humans who recovered from COVID-19. Researchers selected the most potent antibo…

Read more
  • 0